Sydney Jennings

Frontline medical workers dealing with COVID-19 in China have a high risk of developing symptoms of depression, anxiety, insomnia, and distress.

The guidance allows non-medical device manufacturers to produce ventilator parts, hospitals to use ventilators intended for other environments, and more.

Fact or fiction? Vaccines against pneumonia can protect against COVID-19. Plus 8 more questions and answers from the World Health Organization.

A review of US patients with COVID-19 showed that 20% of hospitalizations occurred among adults aged 20-44 years.

Refresh your memory of the week's top headlines on the COVID-19 pandemic with our 5-question pop quiz.

Digestive symptoms can be added to the list of primary complains associated with COVID-19, a new study from China suggests.

A new joint statement from the AHA, HFSA, and ACC urge physicians to continue treatment with ACE-i or ARBs in patients with COVID-19.

New research from Columbia University showed undocumented cases of COVID-19 were responsible for over two-thirds of documented infections in China.

Rx.Health is creating a digital toolkit for hospitals to aid in easier screening and virtual care for COVID-19. 

In a press release today, the FDA announced 2 significant actions it is taking to combat the widespread coronavirus outbreak.

FDA Fast Track designation is to investigate whether the diabetes medication can also reduce kidney disease progression.

How many people have died from coronavirus? How is coronavirus spread? The CDC suggests answers to these and other common questions patients may be asking.

The strongest evidence to date found that fast food alone leads to childhood obesity, adolescent obesity linked to midlife cancer, and 3 more key updates.

All adults starting at age 18 should be screened for hepatitis C, according to newly released recommendations from the US Preventive Services Task Force.

From influenza to herpes zoster, which states ranked the best for vaccination? And which ones did not? Find out in this quick slideshow. 

Drinking 12 oz/day of sugary drinks a day can lower good cholesterol levels and increase triglyceride levels, according to a new prospective study.

The first clinical trial in the US to evaluate an experimental treatment for coronavirus disease in humans is now underway at the University of Nebraska. 

Bempedoic acid is the first oral, once-daily, non-statin cholesterol lowering medication to receive FDA approval since 2002.

Increasing the prevalence of hand hygiene in all airports worldwide by just 10% could slow disease spread by nearly 24%, a recent study found. 

Americans are living longer but not healthier, prompting the American Heart Association to release ambitious 2030 Impact Goals.

Physicians may know how patients can reduce their risk of exposure to coronavirus, but what about their own risk? These CDC-recommended steps offer guidance. 

Sample: Approximately what percentage of physician office visits at which benzodiazepines were coprescribed with opioids were with a primary care provider?

Over 70% of US adults with diabetes have hypertension, 15.6% of these patients have an A1c value >9%, and more fast facts on diabetes risk factors and patient characteristics.

Of the 41% of kratom users who reported taking it for opioid withdrawal, 35% went >1 year without taking opioids or heroin.

From 2013-2016, about 46% of US adults had hypertension. Plus more highlights from the AHA's annual Heart Disease and Stroke Statistical Update. 

The first and only drug to treat peanut allergy recently received approval, giving the growing number of patients a new treatment option.

Over half of coprescriptions were among general or family practice physicians and 40% among internal medicine physicians, a new CDC report suggests. 

In 2018, 9 states reported an adult obesity prevalence of ≥35%. Find out more trends from the CDCs annual Adult Obesity Prevalence Maps.

Sample: Approximately how many alcohol-related deaths were recorded between 1999-2017 among people aged ≥16 years?

The FDA is urging physicians to weigh the benefits and risks of the obesity drug, Belviq™ (lorcaserin), when deciding to start or continue treatment.